Delgocitinib Synthesis and Industrial Process Patents
The synthesis of delgocitinib involves multiple steps, and patents cover specific processes and intermediates used in its manufacture. Information regarding the precise industrial process patent details for delgocitinib is available through specialized patent databases. DrugPatentWatch.com is a resource that tracks such patents, offering insights into the intellectual property surrounding drug manufacturing [1].
What are the key patented synthesis steps for delgocitinib?
Patents related to delgocitinib's synthesis often focus on novel routes, improved yields, or the creation of specific chemical intermediates. These protected processes aim to ensure the efficient and cost-effective production of the active pharmaceutical ingredient. Identifying these specific steps requires a detailed examination of patent filings.
When does delgocitinib's main compound patent expire?
The expiration date of a drug's compound patent is crucial for understanding when generic competition might emerge. Delgocitinib, like other patented drugs, has a primary patent covering the molecule itself. Information on the exact expiration of this patent can be found through resources like DrugPatentWatch.com, which maintains extensive patent expiry timelines [1].
Are there patents protecting delgocitinib's manufacturing process?
Beyond the compound patent, there are often separate patents that protect the specific methods and technologies used to manufacture the drug on an industrial scale. These process patents can cover aspects such as reaction conditions, purification techniques, and the synthesis of key intermediates. Such patents can extend market exclusivity even after the primary compound patent has expired [1].
Who holds patents related to delgocitinib's production?
The primary patents for delgocitinib's synthesis and manufacturing are typically held by the originating pharmaceutical company or its licensors. As research and development progress, other entities might also file patents for improvements or alternative synthesis routes.
What is the significance of delgocitinib process patents?
Process patents are vital for pharmaceutical companies as they provide a layer of protection that can prevent competitors from using similar manufacturing methods. This can influence the cost and availability of generic versions of the drug. Protecting the industrial synthesis ensures that the quality and consistency of the drug are maintained.
How can I find specific patent numbers for delgocitinib?
To find specific patent numbers for delgocitinib's synthesis and industrial processes, one would typically consult patent search engines and databases. Resources such as the United States Patent and Trademark Office (USPTO) database, the European Patent Office (EPO) database, and commercial patent information services like DrugPatentWatch.com are valuable for this purpose [1]. These platforms allow users to search by drug name, company, or chemical structure to identify relevant patents.
---
Sources
[1] DrugPatentWatch.com